Per Sigvald Bakke is a Professor at the University of Bergen's Faculty of Medicine, Department of Clinical Science, with extensive expertise in respiratory medicine. His research primarily focuses on Chronic Obstructive Pulmonary Disease (COPD), asthma, and related pulmonary conditions, with significant contributions to understanding disease mechanisms, clinical phenotyping, and epidemiology. Dr. Bakke's research interests span COPD phenotyping, asthma heterogeneity, genomics of respiratory diseases, pulmonary function testing, and clinical epidemiology. His work frequently involves large-scale cohort studies and international collaborations, particularly through the U-BIOPRED consortium. His research has significantly advanced understanding of COPD progression, exacerbation risk factors, and the relationship between respiratory diseases and systemic conditions like metabolic syndrome. His publication record demonstrates consistent contributions to respiratory medicine, with recent work focusing on multi-omics approaches to disease phenotyping, genetic determinants of lung function, and clinical management of COPD. His research often bridges basic science with clinical application, addressing critical questions in respiratory disease management and patient outcomes. Dr. Bakke has been instrumental in numerous international collaborative studies including the ECLIPSE cohort, U-BIOPRED, and various genome-wide association studies examining COPD and asthma. His work has contributed to clinical guidelines and improved understanding of respiratory disease mechanisms across diverse populations.
جستجوی استاد راهنمای دانشگاهی
برای مسیر پژوهشیتان، استاد راهنما، استاد دانشگاه و پژوهشگر مناسب را پیدا کنید و با آنها ارتباط بگیرید.
نمایش ۱-۱۵ از ۵۲ استاد راهنما
اطلاعات پروفایلها از صفحات عمومی دانشگاهها گرفته شده و ممکن است بهروز نباشد.
Bjørn Olav Åsvold, MD, PhD, is a Professor of Medicine (Epidemiology) and Center leader at the HUNT Centre for Molecular and Clinical Epidemiology (HUNT MCE), Department of Public Health and Nursing, Norwegian University of Science and Technology (NTNU). He also serves as a Consultant at the Department of Endocrinology, St. Olavs Hospital, Trondheim University Hospital. His research spans epidemiology, genetics, and clinical medicine. MD, Norwegian University of Science and Technology, 2001 PhD, Norwegian University of Science and Technology, 2008 Specialist in internal medicine, 2014 Specialist in endocrinology, 2015 Åsvold's research focuses on thyroid dysfunction and diabetes , investigating their interplay with cardiometabolic diseases and pregnancy complications . He utilizes Mendelian randomization studies to explore causal relationships between genetic factors and health outcomes, including sleep traits , autoimmune thyroid disease , and kidney function . His work also addresses global health issues like obesity in Nepal and diabetic complications in Norway. Recent publications highlight his contributions to understanding hip fracture risk prediction , cardiovascular implications of sleep patterns , and genetic determinants of trace elements . Åsvold's collaborations span multiple international institutions, including the HUNT Study and HUNT MCE in Norway.
Kristine Beate Walhovd is a Professor at the Department of Psychology , University of Oslo, and co-leader of the Center for Lifespan Changes in Brain and Cognition (LCBC) . She is affiliated with the UiO:Life Science initiative and has led major projects like Lifebrain (€2.5M) and Neurocognitive Plasticity (ERC Starting Grant, €1.5M). Current roles: Professor (since 2016), Co-leader of LCBC Key affiliations: University of Oslo, Lifebrain Consortium, UiO:Life Science Her research focuses on lifespan brain and cognitive changes , examining both positive/negative developmental trajectories from age 4 to 90. She studies interactions between biomedical risks (e.g., Alzheimer's, fetal drug exposure) and cognitive outcomes, employing MRI , DTI , and ERP methodologies. Recent publications highlight work on Alzheimer's biomarkers , sleep-brain interactions , memory consolidation , and fetal brain influences . Her 2025 papers in Scientific Reports and Neurobiology of Aging examine hippocampal stability and brain network segregation. Awards include: 2015 University of Oslo Research Prize (shared with Anders Fjell) 2011 Member, Norwegian Academy of Sciences and Letters 2006 His Majesty the King's Gold Medal for best doctoral thesis She supervises doctoral candidates and teaches cognitive neuroscience , experimental methods , and thesis writing .
- Cognitive Neuroscience
- Neuropsychology
- Brain Aging
- +۵ مورد دیگر
Ole Andreas Andreassen is a Professor of Psychiatry and Director of the Centre for Precision Psychiatry at the University of Oslo. He holds a joint appointment as an Attending Psychiatrist (20%) at Oslo University Hospital. His academic career includes leadership roles such as Director of the Centre of Excellence NORMENT (2013–2023) and the KG Jebsen Centre for Psychosis Research (2012–2018). He completed his MD (1993) and PhD (1996) at the University of Bergen, followed by postdoctoral training at Harvard Medical School and Massachusetts General Hospital. Education: MD (1993, University of Bergen), PhD (1996, University of Bergen) Postdoc: Harvard Medical School (1998–2000) Specialist in Psychiatry: Oslo University Hospital (2006) His research focuses on mental and neuropsychiatric disorders, emphasizing genetics, brain imaging, and precision medicine. Key areas include the interplay of genetic and environmental factors in schizophrenia, bipolar disorder, and Alzheimer’s disease. He has pioneered studies on predictive tools and clinical interventions, with a strong emphasis on genomic and neuroimaging biomarkers. His publications span over 10 years, addressing topics like cortical abnormalities in bipolar disorder, genetic overlap between psychiatric conditions, and cannabis use impacts. These works highlight interdisciplinary approaches, blending genetics, neuroimaging, and clinical data. Awards: Brain Council Award (2024), Fridtjof Nansen Award (2023), University of Oslo Research Prize (2020) Leadership: Co-Director of the KG Jebsen Centre for Neurodevelopmental Disorders, ENIGMA Bipolar Working Group Chair, and member of the Psychiatric Genomics Consortium. Andreassen has supervised 42 PhD students and co-supervised numerous postdoctoral researchers. His grants and collaborations span EU-funded initiatives (e.g., CoMorMent, RealMent) and global networks like the Precision Psychiatry consortium. Labs and teams include the Centre for Precision Psychiatry and the Scandinavian Collaboration for Psychiatric Etiology (SCOPE), focusing on translational research and multimodal data integration.
Neil Martin Davies is a Researcher at the Department of Public Health and Nursing , Norwegian University of Science and Technology (NTNU) . His work bridges epidemiology, genetics, and public health, with a focus on causal inference, Mendelian randomization, and socioeconomic health disparities. His research explores the intersection of genetic epidemiology , developmental psychology , and clinical outcomes . Key themes include the impacts of antiseizure medications in pregnancy , cardiometabolic risks in psychiatric populations , and health policy implications of Mendelian randomization . Recent publications highlight methodological advancements in directed acyclic graphs (DAGs) , instrumental variable analysis , and family-based sampling . His work frequently addresses parental education effects , sleep patterns , and genetic correlations in large cohorts like UK Biobank. Neil Martin Davies contributes to scientific reporting standards , co-authoring the STROBE-MR guidelines for Mendelian randomization studies. His collaborations span neurology , mental health , and health economics , emphasizing causal relationships over correlational findings.
- Epidemiology
- Genetic Epidemiology
- Public Health
- +۹ مورد دیگر
.jpg)
Espen Moldenمشاهده پروفایل
استاد مدعو
Dr. Espen Molden is an Adjunct Professor at the Department of Pharmacy, University of Oslo, holding a 20% position while serving as Research Manager at the Center for Psychopharmacology, Diakonhjemmet Hospital. He earned his Cand.pharm. degree from the University of Oslo in 1997 and completed his Dr.scient. there in 2003. His primary research focuses on individual variability in drug efficacy and side effects, with particular emphasis on implementing pharmacogenetic knowledge in clinical practice. His research interests span multiple areas of pharmacology, including: Pharmacokinetics and therapeutic drug monitoring Pharmacogenetics (particularly CYP2D6 and CYP2C19) Drug interactions and cytochrome P450 metabolism Clinical applications in psychopharmacology Analysis of his 15 most recent publications (2024-2025) reveals a strong focus on pharmacogenetics applications in clinical settings, particularly in psychopharmacology. His work heavily features therapeutic drug monitoring studies, CYP enzyme polymorphisms, and their clinical implications for antipsychotic and antidepressant treatments. A significant portion of his recent work examines clozapine metabolism, CYP2D6-related pharmacogenetics, and real-world data applications in personalized medicine. His scientific achievements include: Pharmacist of the Year award from the Norwegian Pharmaceutical Association (2006) Extensive publication record in high-impact journals including Nature Genetics, JAMA, and Clinical Pharmacology & Therapeutics Leadership in large collaborative research projects across multiple institutions Dr. Molden actively collaborates with numerous researchers including Professor Torgeir Bruun Wyller at Oslo University Hospital, Professor Anette Hylen Ranhoff at Diakonhjemmet Hospital, and international colleagues from institutions like Karolinska Institutet. His work bridges basic pharmacogenetic research with clinical implementation, particularly in psychiatric medication management.
- Pharmacology
- Pharmacokinetics
- Pharmacogenetics
- +۴ مورد دیگر
Dr. Espen Saxhaug Kristoffersen is an Associate Professor at the Department of General Practice, Faculty of Medicine, University of Oslo, and a Senior Consultant at the Stroke Unit and Department of Neurology, Akershus University Hospital. His academic career spans over a decade with a focus on headache disorders, stroke, and cerebral venous thrombosis. Dr. Kristoffersen earned his Medical Degree (MD) from the University of Tromsø in 2005 after completing medical school from 1999-2005. His educational journey included clinical rotations at various hospitals including Longyearbyen Hospital in Svalbard and Hammerfest Hospital. He completed his PhD in 2014 with the thesis "Brief Intervention for Medication-overuse headache in primary care" through the Department of General Practice at the University of Oslo. Dr. Kristoffersen's research spans multiple neurological domains with primary focus on headache disorders (particularly migraine and medication-overuse headache), stroke (ischemic and hemorrhagic), and cerebral venous thrombosis. His work integrates clinical practice with epidemiological studies, genetic research, and treatment optimization. He has made significant contributions to understanding headache epidemiology, stroke management during pandemics, and the relationship between work schedules and headache frequency. Analysis of Dr. Kristoffersen's recent publications reveals a strong emphasis on cerebrovascular disorders and headache research. His work spans clinical trials, observational studies, and systematic reviews with particular focus on treatment protocols for stroke and headache disorders. Notably, he has contributed to international guidelines and large-scale collaborative studies examining anticoagulation in stroke, headache management in primary care, and neurological complications of infectious diseases including COVID-19. Dr. Kristoffersen has received several prestigious awards recognizing his contributions to neurology and headache research: European Academy of Neurology (EAN) Investigator Award for the subspecialty Headache (2015) Norwegian Neurological Federation - National Headache fellowship (2018) Best poster presentation at the Norwegian Neurology Congress (2018) Forsberg og Aulies legat (2018) Norwegian Neurological Federation – National Neurology Fellowship (2020) Dr. Kristoffersen has led multiple significant research projects including the Long-term follow-up of Brief Intervention for Medication Overuse Headache, studies on neurology residents' knowledge of headache management, and investigations into Norwegian GPs' handling of headache patients. He currently leads several ongoing studies including the Akershus aCute Headache Evaluation (ACHE-1), the Akershus Study of Ischemic Stroke and Thrombolysis (ASIST-1), and epidemiological research on cerebral venous thrombosis in Norway. Dr. Kristoffersen is actively involved in several research groups and international collaborations including the Clinical Neuroscience Group at Akershus University Hospital, the Health Services Research group, the International Cluster Headache Genetics Consortium, the International Migraine Genetics Consortium, and the Global COVID-19 Stroke Registry. He serves as the Norwegian representative to the International Headache Society and European Headache Federation, and contributes to the European Academy of Neurology Scientific Panel on Headache.
Marita Jenssenمشاهده پروفایل
مدرس ارشد
Marita Jenssen is a Senior Lecturer in Skin and Venereological Diseases at the Department of Clinical Medicine , UiT The Arctic University of Norway. Her research focuses on inflammatory skin disorders, particularly psoriasis, and the interplay between vitamin D metabolism and disease epidemiology. Recent studies highlight her work in: Genetic and environmental risk factors for psoriasis miRNA profiling in psoriatic skin Vitamin D supplementation trials for skin disease management Her research spans molecular biology, clinical dermatology, and population health in Arctic regions. Key collaborative efforts include: Dermatoplastic Imaging Research Group Chronic Disease Epidemiology Group
- Inflammatory skin diseases
- Epidemiology
- Psoriasis
- +۲ مورد دیگر
Rolf Jorde is a Professor at the Department of Clinical Medicine , UiT The Arctic University of Norway , with a temporary position as senior consultant in Endocrinology at the University Hospital of Northern Norway . His research focuses on Vitamin D metabolism and its associations with type 2 diabetes , psoriasis , bone turnover , and cardiovascular risk factors , primarily through population-based studies like the Tromsø Study and HUNT Study. His recent publications highlight trends in Vitamin D supplementation trials for metabolic and inflammatory conditions, including diabetes prevention , skin disease outcomes , and longitudinal tracking of vitamin D levels. Collaborations span institutions in Norway and international consortia, with co-authors such as Guri Grimnes , Tom Wilsgaard , and Kevin Cashman .
- Endocrinology
- Vitamin D Metabolism
- Type 2 Diabetes
- +۶ مورد دیگر
Ben Michael Brumpton is an Associate Professor in the Department of Community Medicine and Nursing at the Norwegian University of Science and Technology (NTNU), affiliated with the Faculty of Medicine and Health Sciences. His research focuses on genetic epidemiology, particularly leveraging population-based health surveys (e.g., HUNT Study), electronic health records, and omics data to establish causal relationships in public health. Methodologically, he emphasizes Mendelian randomization and genetic epidemiology frameworks. Major Research Projects: HUNT Genotyping HUNT-COVID Questionnaire HUNT Metabolomics HUNT Methylation Research Interests: His work spans DNA methylation analysis, metabolomics, and the integration of omics data into epidemiological studies. He investigates causal links between genetic traits and diseases such as cardiovascular disorders, cancer, and respiratory conditions. Recent studies have explored intergenerational effects of maternal glycemic traits and parental BMI on offspring health outcomes. Publications Overview: His recent work highlights novel genetic loci for chronic low back pain, venous thromboembolism, and celiac disease. He has also contributed to large-scale meta-analyses of atrial fibrillation and breast cancer risk, emphasizing polygenic prediction and Mendelian randomization approaches. Labs/Teams: Primary affiliation with the HUNT Research Center and collaborations within NTNU’s epidemiology and genetics research groups.
Xiao-Mei Mai serves as Professor in the Department of Public Health and Nursing at the Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), where she has held continuous faculty positions since 2010. Her research is fundamentally anchored in the Norwegian HUNT study, a major population-based health cohort investigation spanning decades. Education: PhD in Medicine, Linköping University, Sweden (2003) Medical degree, Capital Medical University, China (1992) Research Focus: Professor Mai's work centers on causal relationships between Vitamin D status, obesity, and physical activity with chronic disease outcomes. She specializes in Mendelian randomization techniques to investigate connections between reproductive factors/sex hormones and cancer development, epigenetic mechanisms in disease pathways, and respiratory/metabolic disorder epidemiology. Her approach integrates molecular biology with population health data. Publication Trends: Recent work (2022-2025) demonstrates expanding applications of Mendelian randomization across diverse health domains including cognitive decline, oral health, and cancer subtypes. Vitamin D research remains central but now examines interactions with BMI and genetic factors across multiple physiological systems, reflecting increasingly sophisticated causal inference methodologies. Collaborative Framework: As a core HUNT study researcher, she operates within NTNU's interdisciplinary public health infrastructure, frequently collaborating with international teams across Canada, Sweden, and the UK Biobank consortium. Her work bridges epidemiology, clinical medicine, and molecular biology through large-scale data analysis.
- Epidemiology
- Cancer
- Causal Inference
- +۹ مورد دیگر
Øyvind Erik Næss is a Professor at the Department of Community Medicine and Global Health , Faculty of Medicine, University of Oslo. His research focuses on cardiovascular diseases, non-communicable diseases, health inequalities, life course epidemiology, and family-based studies. Current research trends: Genetic and environmental risk factors for cardiovascular disease, life course socioeconomic position, Mendelian randomization, and family-based cohort studies. Recent work includes studies on telomere length and fertility, cognitive ability and familial CVD risk, educational attainment impacts on mortality, and geographic health disparities. He holds editorial roles as a scientific advisor for the Journal of the Norwegian Medical Association and contributes to major projects like the Norwegian Mother, Father, and Child Cohort Study and the Trøndelag Health Study. Collaborations span universities in Trondheim, Bergen, Copenhagen, Bristol, and Glasgow.
Anders Martin Fjell is a Professor and Center Manager for the Center for Lifespan Changes in Brain and Cognition (LCBC) at the Department of Psychology, University of Oslo. His research focuses on how the brain and cognitive abilities develop in childhood and change throughout the adult lifespan. Dr. Fjell's research spans multiple areas of cognitive neuroscience and neuropsychology, with particular emphasis on: Brain development and aging across the lifespan Relationships between brain structure and cognitive function Memory processes and their neural correlates Neurodegenerative processes, particularly related to Alzheimer's Disease Effects of sleep on brain health and cognitive function His publication record demonstrates strong focus on lifespan neuroscience, with recent work examining brain aging trajectories, memory systems, Alzheimer's disease biomarkers, and the relationship between sleep patterns and brain health. His research frequently employs advanced neuroimaging techniques and large-scale longitudinal datasets to investigate cognitive and neural changes across the lifespan. Among his notable achievements: Elected to the Norwegian Academy of Sciences and Letters (2016) Recipient of the University of Oslo Research Prize (2015) LCBC awarded status as one of 5 world-leading research groups at UiO (2015) Morgenbladet's top 10 list of young Norwegian researchers (2012) Recipient of Fridtjof Nansen Award for Young Scientists and His Majesty the King's Gold Medal for best doctoral thesis (2006) Dr. Fjell has secured significant research funding including an ERC Starting Grant (€1.5 million), multiple grants from the Norwegian Research Council, and funding from the National Association for Public Health. His current projects focus on biomarkers for early Alzheimer's detection, brain inflammation and atrophy in aging, and memory development and decline across the lifespan. As Center Manager for LCBC, Dr. Fjell leads one of the world's leading research groups studying lifespan changes in brain and cognition, contributing significantly to our understanding of how the brain changes from childhood through old age.
Linn Beate Strand is an Associate Professor at the Department of Community Medicine and Nursing, Norwegian University of Science and Health Sciences (NTNU), with ongoing work in sleep epidemiology, cardiovascular disease risk factors, and Mendelian randomization. She is affiliated with the Epidemiology and Medical Statistics and MR Nursing research groups. Research Interests: Environmental determinants of health outcomes Population-level sleep disorder analysis Genetic epidemiology of cardiovascular diseases Application of Mendelian randomization Recent Research Trends: Her work bridges sleep science and cardiovascular health through Mendelian randomization, investigating insomnia's role in atrial fibrillation, stroke, and myocardial infarction. She also explores psychosocial factors in nursing education and aging populations' health behaviors. Collaborations: Regularly partners with researchers from University of Bristol, QUT, and St. Olav's Hospital.
Yi-Qian Sunمشاهده پروفایل
پژوهشگر
Yi-Qian Sun is a Senior Researcher in the Department of Clinical and Molecular Medicine at the Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU). Her work focuses on epidemiology, causal inference, and the interplay between lifestyle factors (e.g., vitamin D, body mass index) and chronic diseases such as cancer, dementia, and oral health conditions. PhD in Medicine, Linköping University, Sweden (2004) Medical Degree, Capital Medical University, China (1992) Her research combines genetic epidemiology, epigenetics, and biostatistical modeling to investigate causal relationships between risk factors and disease outcomes. She has led projects on vitamin D as a biomarker for lung cancer, causal links between oral health and systemic health, and Mendelian randomization studies for lifestyle-disease associations. Recent publications highlight her focus on vitamin D metabolism, obesity-related disease risks, and oral-systemic health connections. Her work spans population-based (HUNT Study) and clinical research, utilizing databases like UK Biobank for cross-cohort analyses. Prof. Sun collaborates internationally and applies advanced statistical tools (Stata, R) for study design and data analysis. She leads the HUNT4 Oral Health Study within the GLIDE2 Oral Health Genomics Consortium.
- Epidemiology
- Genetic Epidemiology
- Causal Inference
- +۷ مورد دیگر